Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Historically Controlled Study to Evaluate the Efficacy and Safety of a New Pediatric Formulation of Nifurtimox in Children Aged 0 to 17 Years With Chagas' Disease

NCT02625974 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02625974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02625974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Historically Controlled Study to Evaluate the Efficacy and Safety of a New Pediatric Formulation of Nifurtimox in Children Aged 0 to 17 Years With Chagas' Disease
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
January 27, 2016
Completion date
August 10, 2021
Enrollment
330 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

chagas disease